Sort
64,565 grants matching “drug discovery”
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
$742,757Elizabeth Phillips · Vanderbilt University Medical Center · R01 · FY2019 · HG
Mechanism and Inhibition of HIV Reverse Transcriptase
$742,737Karen S Anderson · Yale University · R01 · FY2023 · AI
Mechanism and Inhibition of HIV Reverse Transcriptase
$742,737Karen S Anderson · Yale University · R01 · FY2022 · AI
Mechanism and Inhibition of HIV Reverse Transcriptase
$742,737Karen S Anderson · Yale University · R01 · FY2020 · AI
Mechanism and Inhibition of HIV Reverse Transcriptase
$742,737Karen S Anderson · Yale University · R01 · FY2021 · AI
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
$742,690David M Spencer · Baylor College Of Medicine · U01 · FY2010 · CA
Nucleocytoplasmic transport: a target for cellular control
$742,658Michael P Rout · Rockefeller University · U01 · FY2012 · GM
PRECLINICAL MEDICATIONS DISCOVERY & ABUSE LIABILITY TESTING FOR NIDA
$742,626Louis S. Harris · Virginia Commonwealth University · N01 · FY2014 · DA
Molecular Targets for Drug Discovery in IPF
$742,500University Of Minnesota Twin Cities · R01 · FY2005 · HL
Molecular Targets for Drug Discovery in IPF
$742,500University Of Minnesota Twin Cities · R01 · FY2004 · HL
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
$742,500Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2020 · CA
Novel lead compound advancement for mitigating halogen-induced mortality and morbidity.
$742,499Shama Ahmad · University Of Alabama At Birmingham · U01 · FY2022 · ES
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
$742,484Leslie S Kean · Seattle Children'S Hospital · R01 · FY2016 · HL
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
$742,442Courtney V. Fletcher · University Of Nebraska Medical Center · R01 · FY2018 · AI
Conjugate vaccines for prevention and treatment of cryptococcosis
$742,433Arturo Casadevall · Johns Hopkins University · R01 · FY2020 · AI
Conjugate vaccines for prevention and treatment of cryptococcosis
$742,433Arturo Casadevall · Johns Hopkins University · R01 · FY2021 · AI
NPQ/Spexin the Endogenous Ligand for the Galanin Receptor 3
$742,361Lawrence R Toll · Torrey Pines Inst For Molecular Studies · R01 · FY2016 · DA
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$742,329Suresh S Ramalingam · Emory University · UG1 · FY2021 · CA
RNAi-dependent epimutation roles in antimicrobial drug resistance and pathogenesis
$742,324Joseph Heitman · Duke University · R01 · FY2023 · AI
ECOLOGICALLY GUIDED BIOPROSPECTING IN PANAMA
$742,209Smithsonian Institution · U01 · FY2000 · TW
Host Genetic Factors Associated with CNS Disease of HIV-Infected Children
$742,181Stephen A Spector · University Of California, San Diego · R01 · FY2012 · NS
Northeast Node of the National Drug Abuse Treatment Clinical Trials Network
$742,151Lisa A Marsch · Dartmouth College · UG1 · FY2025 · DA
Defining an Obesity QTL on Chromosome 3q
$742,125Loyola University Chicago · R01 · FY2005 · HL
Engineering biophysical microtechnologies for hematologic applications in health and disease
$742,114Wilbur A Lam · Emory University · R35 · FY2024 · HL
Genotype-guided therapy for atrial fibrillation
$742,103Dawood Darbar · University Of Illinois At Chicago · R01 · FY2020 · HL